Ladenburg Thalmann Financial Services’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	400	–	–	﹤0.01%	5646
2019 Q3	$2K	Hold	400	–	–	﹤0.01%	5055
2019 Q2	$3K	Sell	400 -100	-20%	-$381	﹤0.01%	4929
2019 Q1	$2K	Buy	500 +100	+25%	+$543	﹤0.01%	5012
2018 Q4	$2K	Hold	400	–	–	﹤0.01%	4978
2018 Q3	$8K	Buy	400 +360	+900%	+$9.1K	﹤0.01%	4420
2018 Q2	$1K	Hold	40	–	–	﹤0.01%	5056
2018 Q1	$1K	Sell	40 -9	-18%	-$592	﹤0.01%	5056
2017 Q4	$4K	Buy	+49	New	+$3.63K	﹤0.01%	4635

Other funds holding MLNT

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MLNT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Melinta Therapeutics, Inc. Common Stock (MLNT) position steady in Q4 2019 at 400 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5646.

Ladenburg Thalmann Financial Services first reported a position in MLNT in Q4 2017 and has held it in 9 quarters since. The position peaked at $8K in Q3 2018. 37 funds tracked by Wall St. Rank hold MLNT as of Q4 2019.

Ladenburg Thalmann Financial Services held 400 shares of Melinta Therapeutics, Inc. Common Stock worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services left its Melinta Therapeutics, Inc. Common Stock share count unchanged in Q4 2019.
Melinta Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5646 holding.
Ladenburg Thalmann Financial Services first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2017 and has held it in 9 quarters since.
Ladenburg Thalmann Financial Services's Melinta Therapeutics, Inc. Common Stock position peaked at $8K in Q3 2018.
37 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.